Article
New splice variants of VEGF as relevant targets for the treatment of renal cell carcinoma
2022-11-07
Abstract excerpt
<title>Abstract</title> <p> Background The efficacy of anti-VEGF/VEGF receptors in the treatment of metastatic clear cell renal cell carcinoma (ccRCC) varies from patient to patient. Discovering the reasons for this variability could lead to the identification of relevant therapeutic targets. We have investigated the possibility of splicing events leading to new forms of VEGF that are less efficiently inhibited...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 30ba5f87-0fb7-55ee-88da-d89a3d2c805d
- DOI
- 10.21203/rs.3.rs-1684822/v2
